Multivitamin (multivitamin/mineral) trials recruiting now

15 registrations that name multivitamin as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 15 registrations

Status

Phase

3US sites across 2 states

All 15 registrations

RecruitingNCT06811233

Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study

  • Phase 2
  • M.D. Anderson Cancer Center
  • About 140 people
  • Started May 8, 2025

In plain words A Phase 2 study of multivitamin in people 18 and older, run by M.D. Anderson Cancer Center. It plans to enroll about 140 people at 1 US site.

Who it lists and where

Who the trial lists, as registered

Lists people 18 and older. Conditions: Acute Myeloid Leukemia (AML).

  • Understand and voluntarily sign an informed consent form for participants 18 years or older, unless LAR signs where applicable along with any required verbal assents if patients can provide assent.
  • Age 18 years or older at the time of signing the informed consent form.
  • Diagnosis of Any of the Following:
  • Newly diagnosed (or untreated) AML or Newly diagnosed Myeloproliferative Neoplasm in Myeloid Blast Phase (MPN-BP) \[including Chronic Myeloid Leukemia in Blast Phase (CML-BP)\], Ph+AML with intermediate-risk or high-risk (by ELN), or any…

14 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

DMSA; Ca-EDTA; Magnesium Sulfate; Multivitamin

Registered summary

The goal of this clinical research study is to learn if metal detoxification (with calcium disodium edetate \[Ca-EDTA\] and dimercaptosuccinic acid \[DMSA\]) during standard therapy can help improve outcomes in patients with intermediate-risk, high-risk, or secondary AML compared to standard therapy alone. Researchers think lowering the level of metals found in the blood/bone marrow may help to control the disease and/or improve the response to chemotherapy.

Where, as registered

1 US site in 1 state.

RecruitingNCT03630991

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

  • Phase 1
  • M.D. Anderson Cancer Center
  • About 58 people
  • Started Oct 11, 2018

In plain words A Phase 1 study of multivitamin in people 1 and older, run by M.D. Anderson Cancer Center. It plans to enroll about 58 people at 1 US site.

Who it lists and where

Who the trial lists, as registered

Lists people 1 and older. Conditions: Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Risk Myelodysplastic Syndrome; Myelodysplastic Syndrome; Myelodysplastic/Myeloproliferative Neoplasm; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Myelodysplastic Syndrome; Recurrent Myelodysplastic/Myeloproliferative Neoplasm; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Refractory Myelodysplastic Syndrome; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndrome; Very High Risk Myelodysplastic Syndrome.

  • Patients ≥18 years of age, or their legally authorized representative (LAR), must have the ability to understand the requirements of the study and must voluntarily sign the informed consent form.
  • Age ≥18 years at the time of signing the informed consent form.
  • Age ≥1 years and <18 years with weight requirement ≥8 kg at the time of the signing of the informed consent form (e.g. by parent or LAR)
  • Patients enrolling in the pediatric/adolescent/young adult exploratory cohort must be:

21 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Edetate Calcium Disodium; Multivitamin; Succimer

Registered summary

This phase I trial studies the side effects and best dose of edetate calcium disodium or succimer in treating patients with acute myeloid leukemia or myelodysplastic syndrome undergoing chemotherapy. Edetate calcium disodium or succimer may help to lower the level of metals found in the bone marrow and blood and may help to control the disease and/or improve response to chemotherapy.

Where, as registered

1 US site in 1 state.

RecruitingNCT06666660

Daily Intake of Multivitamin & Mineral Supplementation Effects on Biological Age of Relatively Healthy Middle-aged Individuals

  • No phase
  • National University of Singapore
  • About 400 people
  • Started Sep 23, 2024

In plain words A study of multivitamin in people 40 to 60, run by National University of Singapore. It plans to enroll about 400 people at 2 sites, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 40 to 60; healthy volunteers accepted. Conditions: Relatively Healthy Volunteers.

  • Relatively healthy middle aged (40-60 years) man or woman;
  • Completed the pre-screening requirements and has managed to schedule the screening visit;
  • Met the randomization criteria after the screening visit i.e., your biological age (as measured by blood DNA methylation) is greater than the chronological age;
  • Able to attend all 4 research visits for screening and research data collection at the NUHS Centre for Healthy Longevity (CHL) at Alexandra Hospital or MD11, National University of Singapore.

2 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Multivitamin/Mineral supplements; Placebo

Registered summary

Micronutrients, such as vitamins and minerals, are required to sustain fundamental physiological processes in individuals. As individuals age, the risk of having suboptimal levels of micronutrients increases due to several age-related changes affecting their digestion and assimilation processes. Suboptimal levels of micronutrients have been associated with increased risk of chronic diseases and accelerated ageing. Three years intake of a multivitamin and mineral supplement (MVM) improved global cognition, episodic memory and executive function in older adults. The full summary is on the listing.

Where, as registered

No US site; Singapore (2).

RecruitingNCT07433049

Impact of Supplementation in Improving Metabolic Health Outcomes (ISMOS) Study

  • No phase
  • Institute for Human Development and Potential (IHDP), Singapore
  • About 400 people
  • Started Jan 20, 2026

In plain words A study of multivitamin in female participants 40 to 60, run by Institute for Human Development and Potential (IHDP), Singapore. It plans to enroll about 400 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists female participants 40 to 60; healthy volunteers accepted. Conditions: Glucose Control; Mental Health; Musculoskeletal Health; Body Composition.

  • Women aged 40-60 years old
  • Chinese, Malay or Indian
  • BMI between 23.0-35.0 kg/m2
  • Proficient in English language

1 more inclusion criterion and the exclusion criteria are on the listing.

What it tests, as registered

Multivitamin/mineral study product

Registered summary

This study investigates the role of multivitamin and multimineral (MVM) supplementation in improving metabolic, musculoskeletal, and mental health among midlife Asian women aged 40-60 years, a critical period marked by hormonal and physiological transitions from pre- to post-menopause. Evidence from the GUSTO cohort in Singapore has shown that higher plasma levels of vitamins B6, B9, B12, and D are associated with better metabolic profiles, insulin sensitivity, and mental wellbeing, while deficiencies are linked to increased metabolic and psychological risks. The full summary is on the listing.

Where, as registered

No US site; Singapore (1).

RecruitingNCT07383974

The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status

  • No phase
  • ChinaNorm
  • About 120 people
  • Started Nov 3, 2025

In plain words A study of multivitamin in people 18 and older, run by ChinaNorm. It plans to enroll about 120 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 18 and older; healthy volunteers accepted. Conditions: Healthy Volunteers; Dietary Supplementation; Skin Health; Health Status; Antioxidants.

  • Chinese adults of Asian descent aged 18 and above;
  • Daily fruit and vegetable intake < 240g (calculated based on the fruit and vegetable section of the food frequency questionnaire);
  • S3 measurement index < 30000;
  • Participants must possess basic Chinese reading comprehension and expression skills, and be able to independently complete questionnaire surveys;

2 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Vitamin C & Green Tea Capsules + Multivitamin & Mineral Capsules Combination; Placebo Combination (Matching)

Registered summary

This is a randomized, double-blind, placebo-controlled clinical trial exploring the effects of a 12-week dietary supplement regimen on skin condition and perceived overall health status. The study will involve 120 healthy Chinese adults aged 18 and above with low daily fruit and vegetable intake. Participants will be randomly assigned to one of two groups: one group will take a combination of Nu Skin's Vitamin C \& Green Tea Capsules and Multivitamin \& Mineral Capsules, while the other group will take a matching placebo. The full summary is on the listing.

Where, as registered

No US site; China (1).

RecruitingNCT07397572

Iron Supplementation and Anemia After Sleeve Gastrectomy

  • Observational
  • Cairo University
  • About 66 people
  • Started Jan 17, 2026

In plain words An observational study of multivitamin in people 18 to 65, run by Cairo University. It plans to enroll about 66 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 18 to 65. Conditions: Iron Deficiency Anemia; Obesity; Sleeve Gastrectomy.

  • Adults aged 18 to 65 years scheduled to undergo primary laparoscopic sleeve gastrectomy (LSG).
  • Capable of understanding and providing written informed consent for participation.
  • Able and willing to commit to the 6-month post-operative follow-up schedule at the bariatric clinic.

The exclusion criteria are on the listing.

What it tests, as registered

Elemental Iron; Multivitamin with Minerals

Registered summary

The goal of this observational study is to learn if taking extra iron pills after weight loss surgery helps prevent low iron and anemia compared to just taking a standard multivitamin. The main question it aims to answer is: Does a specific iron supplementation plan lower the number of patients who develop iron deficiency anemia in the 6 months after sleeve gastrectomy surgery? Researchers will compare two groups of patients from different hospital units to see if the extra iron works: Patients from one unit who take a prophylactic iron supplement (Ferrodep, 60 mg per day) in addition to… The full summary is on the listing.

Where, as registered

No US site; Egypt (1).

RecruitingNCT07451496

PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)

  • No phase
  • National University of Singapore
  • About 20 people
  • Started Sep 29, 2025

In plain words A study of multivitamin in people 50 to 80, run by National University of Singapore. It plans to enroll about 20 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 50 to 80; healthy volunteers accepted. Conditions: Ageing.

  • Age 50-80 years (both male and female)
  • Relatively healthy and in stable health condition
  • Not engaged in regular resistance or aerobic training in the past 12 months (i.e., untrained)
  • VO₂peak below the 75th percentile for age- and sex-specific norms

6 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Sleep and dietary counseling; Supervised exercise and exergaming program; Motivational interviewing; Whey protein; Creatine Monohydrate; Fucoidan; Urolithin A; Nicotinamide Mononucleotide (NMN); Multivitamin; Ergothioneine

Registered summary

As the population ages, the growing prevalence of age-related diseases is creating substantial challenges for healthcare systems worldwide. Current therapeutic strategies often target individual diseases and decrease mortality without improving healthspan. The geroscience hypothesis suggests that targeting the ageing process itself could prevent, delay, or manage the severity of multiple age-related diseases concurrently, thereby improving overall healthspan and reducing healthcare burdens. The full summary is on the listing.

Where, as registered

No US site; Singapore (1).

Not yet recruitingNCT07736768

Vitamin A Supplementation and Breast Milk Vitamin A Levels in Mothers of Preterm Infants

  • No phase
  • University of Mississippi Medical Center
  • About 20 people
  • Starts Aug 1, 2026 (estimated)

In plain words A study of multivitamin in people 18 to 45, run by University of Mississippi Medical Center. It plans to enroll about 20 people at 1 US site.

Who it lists and where

Who the trial lists, as registered

Lists people 18 to 45. Conditions: Premature; Preterm Infant Health; Vitamin A Deficiency; Human Milk; Breastfeeding.

  • Mothers aged 18 to 45 years Delivered an infant born at less than 29 weeks' gestation Intending to provide breast milk for at least 4 months postpartum Willing and able to swallow oral tablets Willing to comply with study procedures,…

The exclusion criteria are on the listing.

What it tests, as registered

Oral multivitamin containing vitamin A

Registered summary

Preterm infants are at increased risk of vitamin A deficiency because they are born with low vitamin A stores and depend largely on breast milk to meet their nutritional needs. This study will evaluate whether daily maternal vitamin A supplementation increases vitamin A concentrations in the breast milk of mothers who deliver infants before 29 weeks of gestation. Participants will receive a commercially available oral multivitamin supplement containing 1,300 mcg retinol activity equivalents (RAE) of vitamin A daily for four months after delivery. The full summary is on the listing.

Where, as registered

1 US site in 1 state.

Not yet recruitingNCT06816524

The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron Deficiency

  • No phase
  • Nicole Stoffel
  • About 324 people
  • Starts Jan 5, 2026 (estimated)

In plain words A study of multivitamin in people 6 months to 6 months, run by Nicole Stoffel. It plans to enroll about 324 people and lists no sites yet.

Who it lists and where

Who the trial lists, as registered

Lists people 6 months to 6 months. Conditions: Iron Deficiencies.

  • Subject's caregiver is willing and able to give informed consent
  • Male or Female, 6 months (+/- 2 weeks) of age
  • Mother at least ≥15 years of age
  • Iron deficient (erythrocyte zinc protoporphyrin (ZnPP) >61 μmol/mol heme)

1 more inclusion criterion and the exclusion criteria are on the listing.

What it tests, as registered

Iron syrup; Multivitamin syrup; R21-Matrix/M Vaccine (malaria vaccine); Measles-Rubella vaccine

Registered summary

Malaria and iron deficiency cause a significant burden of disease in Africa. Iron deficiency (ID) might affect immune responses to vaccination. In this double-blind randomized controlled trial, we aim to assess: (1) whether ID impairs R21/Matrix-M and measles (MR) vaccine response, (2) whether iron treatment at time of vaccination improves vaccine response.

Where, as registered

No sites listed yet.

Not yet recruitingNCT07622147

Immune-Mitochondrial Correction in Military Recruits

  • No phase
  • MIPO Clinic
  • About 200 people
  • Starts Jan 1, 2027 (estimated)

In plain words A study of multivitamin in male participants 18 to 27, run by MIPO Clinic. It plans to enroll about 200 people and lists no sites yet.

Who it lists and where

Who the trial lists, as registered

Lists male participants 18 to 27; healthy volunteers accepted. Conditions: Respiratory Tract Infections (RTI); Meningitis; Primary Prevention/Methods; Primary Prevention; Mitochondrial Biomarkers; Immuno-monitoring; Immuno-modulation.

  • Male military recruits aged 18-27 years
  • Starting initial military training at the Military Clinical Hospital of the Ministry of Defense of the Republic of Kazakhstan (Almaty)
  • Signed informed consent
  • No acute infectious diseases at enrollment

2 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Multivitamin/Mineral supplements; Sodium nucleinate combination

Registered summary

The goal of this clinical trial is to learn if a new immune-mitochondrial correction strategy works better than standard vitamins to prevent infections in young male military recruits during their first 6 months of service. The main questions it aims to answer are: 1. Does the new strategy lower the number of recruits who get infections (like colds, flu, or pneumonia) over 6 months? 2. The full summary is on the listing.

Where, as registered

No sites listed yet.

Not yet recruitingNCT07863050

Unflavored Powdered Multivitamin in Children

  • No phase
  • EllaOla
  • About 166 people
  • Starts Oct 14, 2026 (estimated)

In plain words A study of multivitamin in people 4 to 11, run by EllaOla. It plans to enroll about 166 people and lists no sites yet.

Who it lists and where

Who the trial lists, as registered

Lists people 4 to 11; healthy volunteers accepted. Conditions: Selective Eating; Emotional Dysregulation; Child Behavior; Healthy Children (Wellness Study).

  • Healthy child aged 4-11 years at time of enrollment, male or female
  • Not currently taking oral over-the-counter supplements or another multivitamin, if they are taking, must discontinue use for at least four weeks prior to randomization and for the duration of the study.
  • Parent reports active concern/challenge in behavior and selective eating confirmed by minimum threshold scores on three screening instruments: a.
  • Generally healthy as determined by caregiver report without any chronic medical condition that is unstable is actively being treated with medication changes, or that in the judgment of the Investigator would interfere with study…

7 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

EllaOla Kids Essentials Unflavored Powdered Multivitamin; Placebo (Tapioca Fiber)

Registered summary

The goal of this clinical trial is to learn whether a daily unflavored powdered multivitamin (EllaOla Kids Essentials) improves mood and behavior in children aged 4 to 11 who are picky eaters and experience behavioral challenges. Researchers will also look at whether the multivitamin affects overall health, well-being, nutrition, and serum vitamin levels, and whether it is safe and well tolerated. The full summary is on the listing.

Where, as registered

No sites listed yet.

Not yet recruitingNCT07130396

Impact of Multivitamin (PhytoMulti®) and a Probiotic (UltraFlora® Balance Probiotic) on Gut Health of People Taking GLP-1 Medication

  • No phase
  • Metagenics, Inc.
  • About 100 people
  • Starts Nov 1, 2025 (estimated)

In plain words A study of multivitamin in people 18 and older, run by Metagenics, Inc.. It plans to enroll about 100 people and lists no sites yet.

Who it lists and where

Who the trial lists, as registered

Lists people 18 and older; healthy volunteers accepted. Conditions: GLP-1; Adults.

  • Providing written informed consent
  • Males and females of at least 18 years old
  • Minimum 4 weeks on GLP-1 (f.e Ozempic®, Wegovy®, Mounjaro®, etc.) and maximum 1 year on GLP-1
  • Body Mass Index (BMI) ≥ 25 AND ≤ 30

2 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Multivitamin and a Probiotic

Registered summary

This is a single-arm, open-label clinical trial involving 100 participants who will undergo a total participation period of 12 weeks.

Where, as registered

No sites listed yet.

Not yet recruitingNCT07138391

Chamomile Gummies and Pediatric Dental Anxiety

  • Phase 2 and 3
  • Ain Shams University
  • About 78 people
  • Starts Aug 2025 (estimated)

In plain words A Phase 2 and 3 study of multivitamin in people 5 to 8, run by Ain Shams University. It plans to enroll about 78 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 5 to 8; healthy volunteers accepted. Conditions: Dental Anxiety.

  • Patients exhibiting Frankl's behavior rating grade III or IV.
  • Children requiring invasive dental treatment in their primary teeth

The exclusion criteria are on the listing.

What it tests, as registered

chamomile gummy; a multivitamin gummy

Registered summary

The aim of this study is to evaluate the effect of oral chamomile on reducing dental anxiety in children. Anxiety assessments will be done by recording the pulse rate and blood pressure and by using modified child dental anxiety scale.

Where, as registered

No US site; Egypt (1).

Not yet recruitingNCT07837817

The Impact of a Daily Dietary Supplement on Glycemic Control in Individuals With Overweight or Obesity

  • No phase
  • University of South Alabama
  • About 60 people
  • Starts Oct 2026 (estimated)

In plain words A study of multivitamin in people 18 to 65, run by University of South Alabama. It plans to enroll about 60 people and lists no sites yet.

Who it lists and where

Who the trial lists, as registered

Lists people 18 to 65. Conditions: Glycemic Control; Appetite Regulation.

  • BMI 25-40 kg/m²
  • Ability to provide informed consent

The exclusion criteria are on the listing.

What it tests, as registered

natural glycemic control supplement; Placebo Multivitamin

Registered summary

This clinical trial will evaluate the efficacy of Metabolic Master Pack over a 90-day intervention period. Sixty adults will be randomized to receive either Metabolic Master Pack or placebo. Participants will wear continuous glucose monitors throughout the study, complete repeated blood collections, undergo DEXA body composition assessments, and complete dietary records. Results will provide high-quality evidence regarding the product's effects on glucose regulation and metabolic health.

Where, as registered

No sites listed yet.

Not yet recruitingNCT06795789

Multivitamin Intervention and Cognitive Function

  • No phase
  • Braincare Limited
  • About 30 people
  • Starts Mar 1, 2025 (estimated)

In plain words A study of multivitamin in people 18 and older, run by Braincare Limited. It plans to enroll about 30 people at 2 sites, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 18 and older; healthy volunteers accepted. Conditions: Healthy Adult; Cognitive Measures.

  • Healthy Men and Women age >18 years
  • Newly subscribed to the nutritional supplement
  • Access to a PC or laptop with internet connection

The exclusion criteria are on the listing.

What it tests, as registered

Vitals+ (combined multivitamin and polyphenol supplement)

Registered summary

The purpose of this trial is to learn how a multivitamin combined blueberry polyphenol supplement (Vitals+) influences cognitive function in healthy adults. A secondary aim is to see how the biochemical level of nutritional factors change with the supplement. This study will be completed fully remote (from the participants home without in-person visits). The full summary is on the listing.

Where, as registered

No US site; United Kingdom (2).

ClinicalTrials.gov lists 46 open registrations for this search, including ones where multivitamin is not a study arm or that are past the 15 we keep. Search them on ClinicalTrials.gov (opens in new tab).

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.